Abreu Advogados, portuguese law firm, advised a Mercurius Health's management team on the acquisition of a controlling position, in a co-investment with Nexxus Iberia, a venture capital fund with a presence in Portugal, Spain and Mexico.
Mercurius Health is a leading radiotherapy company in Portugal, with subsidiaries in Mozambique and Portugal.
Abreu Advogados advised the acquisition in the Due Diligence phase to Mercurius Health and in the negotiation of the purchase and sale contract and conclusion of the transaction, and also advised the management team in the negotiation of the co-investment contract with Nexxus Iberia.
Abreu team was led by Corporate and M&A partner António Pina with the participation of honorary partner Miguel Teixeira de Abreu. A multidisciplinary team participated in the Due Diligence phase involving partners Ricardo Henriques, Mafalda Teixeira de Abreu and Patrícia Perestrelo and associates André Modesto Pinheiro, António Frusoni Gonçalves, António Vidal and Luísa Esteves da Fonseca.
Cuatrecasas worked in partnership with a team at Abreu Advogados, as advisors to co-investors, coordinated by partner António Pina with the participation of honorary partner Miguel Teixeira de Abreu.